0001140361-16-064987.txt : 20160513 0001140361-16-064987.hdr.sgml : 20160513 20160513113325 ACCESSION NUMBER: 0001140361-16-064987 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160331 FILED AS OF DATE: 20160513 DATE AS OF CHANGE: 20160513 EFFECTIVENESS DATE: 20160513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEXTHERA CAPITAL LP CENTRAL INDEX KEY: 0001646343 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-17280 FILM NUMBER: 161646792 BUSINESS ADDRESS: STREET 1: 900 THIRD AVENUE STREET 2: SUITE 1100 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 213-7033 MAIL ADDRESS: STREET 1: 900 THIRD AVENUE STREET 2: SUITE 1100 CITY: NEW YORK STATE: NY ZIP: 10022 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001646343 XXXXXXXX 03-31-2016 03-31-2016 NEXTHERA CAPITAL LP

900 THIRD AVENUE SUITE 1100 NEW YORK NY 10022

13F HOLDINGS REPORT 028-17280 N Daniel Malek 6462137033 /s/ Daniel Malek New York NY 05-13-2016 0 32 96539 false INFORMATION TABLE 2 form13fInfoTable.xml Adamas Pharmaceuticals Inc COM 00548A106 1692 117000 SH SOLE 117000 0 0 Advaxis Inc COM NEW 007624208 903 100000 SH SOLE 100000 0 0 Aerie Pharmaceuticals Inc COM 00771V108 733 60280 SH SOLE 60280 0 0 Allergan plc SHS G0177J108 7371 27500 SH SOLE 27500 0 0 BioPharmX Corp COM 09072X101 377 345440 SH SOLE 345440 0 0 Bristol Myers Squibb Co COM 110122108 6452 101000 SH SOLE 101000 0 0 Celgene Corp COM 151020104 13512 135000 SH SOLE 135000 0 0 Concert Pharmaceuticals Inc COM 206022105 2500 183000 SH SOLE 183000 0 0 Cynapsus Therapeutics Inc COM PAR NO PAR 23257Y859 401 33716 SH SOLE 33716 0 0 Eagle Pharmaceuticals Inc COM 269796108 1337 33000 SH Put SOLE 33000 0 0 Exelixis Inc NOTE 4.250% 8/1 30161QAC8 1991 2000000 PRN SOLE 2000000 0 0 Five Prime Therapeutics Inc COM 33830X104 813 20000 SH SOLE 20000 0 0 Horizon Pharma Plc SHS G4617B105 3645 220000 SH SOLE 220000 0 0 Ignyta Inc COM 451731103 1016 150000 SH SOLE 150000 0 0 Immune Design Corp COM 45252L103 1107 85138 SH SOLE 85138 0 0 ImmunoGen Inc COM 45253H101 1943 228000 SH SOLE 228000 0 0 Infinity Pharmaceuticals Inc COM 45665G303 764 145000 SH SOLE 145000 0 0 Insmed Inc COM PAR $.01 457669307 507 40000 SH SOLE 40000 0 0 Lannett Inc COM 516012101 2690 150000 SH SOLE 150000 0 0 Lion Biotechnologies Inc COM 53619R102 774 152266 SH SOLE 152266 0 0 Minerva Neurosciences Inc COM 603380106 209 34100 SH SOLE 34100 0 0 Mylan NV SHS EURO N59465109 6304 136000 SH SOLE 136000 0 0 Neurocrine Biosciences Inc COM 64125C109 1661 42000 SH SOLE 42000 0 0 Neuroderm Ltd ORD SHS M74231107 988 70000 SH SOLE 70000 0 0 Pfizer Inc COM 717081103 12923 436000 SH SOLE 436000 0 0 Progenics Pharmaceuticals In COM 743187106 419 96000 SH SOLE 96000 0 0 Sanofi SPONSORED ADR 80105N105 4699 117000 SH SOLE 117000 0 0 Seattle Genetics Inc COM 812578102 3614 103000 SH SOLE 103000 0 0 Shire PLC SPONSORED ADR 82481R106 13099 76200 SH SOLE 76200 0 0 Tobira Therapeutics Inc COM 88883P101 368 45000 SH SOLE 45000 0 0 UniQure NV SHS N90064101 1366 115000 SH SOLE 115000 0 0 XenoPort Inc COM 98411C100 361 80000 SH SOLE 80000 0 0